Genomic Expression is finding the best drug for the patient and the best patient for the drug by sequencing RNA and linking alteration to dugs through its proprietary algorithms and databases. Analyzing RNA is able to tell if the tumor will respond to the new immune therapies, which is the only kind of therapy that is a potential cure. Right now only 1 out if 4 cancer treatments prolong life while we are spending $100 Billion on drugs every year and 8 million patients die. Genomic Expression was started as the diagnostic partner in the $32M Danish “Genome Denmark” and has now 4 in-house clinical programs established in selected indications with clear unmet needs. The OneRNA™ test itself can be used on any type of cancer.